Caribou Biosciences
is an derived car cell therapy for solid tumor targeting | Caribou Biosciences
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
38 of 44
Related slides by other companies
AstraZeneca
Investor Conference
January 2024
strong business development momentum through | AstraZeneca
MaxCyte
Investor Presentation
January 2024
business model cell therapy market | MaxCyte
Evotec
Investor Presentation
July 2022
delivering off the shelf cell therapy products to patients one | Evotec
Enochian Biosciences
Results
August 2023
plus gamma delta cells as potential therapy for | Enochian Biosciences
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights